| Item Type | Name |
|
Academic Article
|
Does preoperative statin therapy improve outcomes in patients undergoing isolated cardiac valve surgery?
|
|
Academic Article
|
Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future.
|
|
Academic Article
|
Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.
|
|
Academic Article
|
Barriers to non-HDL cholesterol goal attainment by providers.
|
|
Academic Article
|
Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery.
|
|
Academic Article
|
The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis.
|
|
Academic Article
|
Lipid management: considerations in acute coronary syndrome.
|
|
Academic Article
|
Preoperative statin therapy decreases risk of postoperative renal insufficiency.
|
|
Academic Article
|
Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
|
|
Academic Article
|
Association between statins and infections after coronary artery bypass grafting.
|
|
Academic Article
|
Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
|
|
Academic Article
|
LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia.
|
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
|
Academic Article
|
Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths.
|
|
Academic Article
|
Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis.
|
|
Academic Article
|
Rare LPL gene variants attenuate triglyceride reduction and HDL cholesterol increase in response to fenofibric acid therapy in individuals with mixed dyslipidemia.
|
|
Academic Article
|
Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines.
|
|
Academic Article
|
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.
|
|
Academic Article
|
Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
|
|
Academic Article
|
Gender disparities in evidence-based statin therapy in patients with cardiovascular disease.
|
|
Academic Article
|
Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry).
|
|
Academic Article
|
Differential Lipid Response to Statins Is Associated With Variants in the BUD13-APOA5 Gene Region.
|
|
Academic Article
|
Implications for Ezetimibe Therapy Use Based on IMPROVE-IT Criteria.
|
|
Academic Article
|
Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
|
|
Academic Article
|
Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline.
|
|
Academic Article
|
Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.
|
|
Academic Article
|
Using a tailored health information technology- driven intervention to improve health literacy and medication adherence in a Pakistani population with vascular disease (Talking Rx) - study protocol for a randomized controlled trial.
|
|
Academic Article
|
Statin Use and Its Facility-Level Variation in Patients With Diabetes: Insight From the Veterans Affairs National Database.
|
|
Academic Article
|
Lipid Management Guidelines from the Departments of Veteran Affairs and Defense: A?Critique.
|
|
Academic Article
|
Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies.
|
|
Academic Article
|
Practice-Level Variation in?Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry.
|
|
Academic Article
|
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.
|
|
Academic Article
|
Comparative effectiveness of outpatient cardiovascular disease and diabetes care delivery between advanced practice providers and physician providers in primary care: Implications for care under the Affordable Care Act.
|
|
Academic Article
|
Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
|
|
Academic Article
|
Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
|
|
Academic Article
|
Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013.
|
|
Academic Article
|
Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial.
|
|
Academic Article
|
Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.
|
|
Academic Article
|
Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry.
|
|
Academic Article
|
National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel?Survey.
|
|
Academic Article
|
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.
|
|
Academic Article
|
Statin Use and Adverse Effects Among Adults >75?Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
|
|
Academic Article
|
Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
|
|
Academic Article
|
Association between intensity of statin therapy and mortality in persons with chronic kidney disease.
|
|
Academic Article
|
Frequency of Statin Use in Patients With Low-Density Lipoprotein Cholesterol =190 mg/dl from the Veterans Affairs Health System.
|
|
Academic Article
|
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry.
|
|
Academic Article
|
Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
|
|
Academic Article
|
Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences.
|
|
Academic Article
|
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines.
|
|
Academic Article
|
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines.
|
|
Academic Article
|
Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry).
|
|
Academic Article
|
Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
Making prescriptions "talk" to stroke and heart attack survivors to improve adherence: Results of a randomized clinical trial (The Talking Rx Study).
|
|
Academic Article
|
Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.
|
|
Academic Article
|
Omega-3 Fatty Acid and Cardiovascular Outcomes: Insights From Recent Clinical Trials.
|
|
Academic Article
|
Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease.
|
|
Academic Article
|
Measurement of Low-Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry.
|
|
Academic Article
|
Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options.
|
|
Academic Article
|
2018 Cholesterol Guidelines: Key Topics in Primary Prevention.
|
|
Academic Article
|
CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?
|
|
Academic Article
|
Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry.
|
|
Academic Article
|
Four Cases of Cholesterol Management Informed by the 2018 American Heart Association/American College of Cardiology Multisociety Guideline on the Management of Blood Cholesterol.
|
|
Academic Article
|
The 2018 Cholesterol Management Guidelines: Topics in Secondary ASCVD Prevention Clinicians Need to Know.
|
|
Academic Article
|
ApoB, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change.
|
|
Academic Article
|
Association Between Lipid Testing and Statin Adherence in the Veterans Affairs Health System.
|
|
Academic Article
|
Major Randomized Clinical Trials in Cardiovascular Disease Prevention Presented at the 2019 American College of Cardiology Annual Scientific Session.
|
|
Academic Article
|
Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry.
|
|
Academic Article
|
Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.
|
|
Academic Article
|
Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018?AHA/ACC Cholesterol Guidelines.
|
|
Academic Article
|
Relation Between Cardiology Follow-Up Visits, Evidence-Based Statin Prescribing, and Statin Adherence (from the Veterans Affairs Health Care System).
|
|
Academic Article
|
Sex Differences in the Use of Statins in Community Practice.
|
|
Academic Article
|
The use of structured data elements to identify ASCVD patients with statin-associated side effects: Insights from the Department of Veterans Affairs.
|
|
Academic Article
|
Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
|
|
Academic Article
|
Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
|
|
Academic Article
|
Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system.
|
|
Academic Article
|
Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System).
|
|
Academic Article
|
Coronary Artery Calcification, Statin Use and Long-Term Risk of Atherosclerotic Cardiovascular Disease Events (from the Multi-Ethnic Study of Atherosclerosis).
|
|
Academic Article
|
Association Between Poverty and Appropriate Statin Prescription for the Treatment of Hyperlipidemia in the United States: An Analysis From the ACC NCDR PINNACLE Registry.
|
|
Academic Article
|
Real-world data, theoretical application of guidelines, cost, and access: how do we optimize non-statin therapy for LDL-C/non-HDL-C/ApoB?
|
|
Academic Article
|
Triglycerides and ASCVD Risk Reduction: Recent Insights and Future Directions.
|
|
Academic Article
|
Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry.
|
|
Academic Article
|
Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD.
|
|
Academic Article
|
Novel emerging therapies in atherosclerosis targeting lipid metabolism.
|
|
Academic Article
|
Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.
|
|
Academic Article
|
Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond.
|
|
Academic Article
|
Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.
|
|
Academic Article
|
Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy.
|
|
Academic Article
|
How low is safe? The frontier of very low (<30 mg/dL) LDL cholesterol.
|
|
Academic Article
|
Facility-Level Variation in Reported Statin-Associated Side Effects Among Patients with Atherosclerotic Cardiovascular Disease-Perspective from the Veterans Affair Healthcare System.
|
|
Academic Article
|
Efficacy and safety for the achievement of guideline-recommended lower low-density lipoprotein cholesterol levels: a systematic review and meta-analysis.
|
|
Academic Article
|
Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry.
|
|
Academic Article
|
Statins in COVID-19 infection: A rehash of old themes or truly a new hope?
|
|
Academic Article
|
Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database).
|
|
Academic Article
|
Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
|
|
Academic Article
|
Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures?
|
|
Academic Article
|
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee.
|
|
Academic Article
|
Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.
|
|
Academic Article
|
Epidemiology and risk factors for stroke in young individuals: implications for prevention.
|
|
Academic Article
|
Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network.
|
|
Academic Article
|
High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better.
|
|
Academic Article
|
Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system.
|
|
Academic Article
|
Association of Low-Density Lipoprotein Testing After an Atherosclerotic Cardiovascular Event with Subsequent Statin Adherence and Intensification.
|
|
Academic Article
|
Potential Impact of the 2019 ACC/AHA Guidelines on the Primary Prevention of Cardiovascular Disease Recommendations on the Inappropriate Routine Use of Aspirin and Aspirin Use Without a Recommended Indication for Primary Prevention of Cardiovascular Disease in Cardiology Practices: Insights From the NCDR PINNACLE Registry.
|
|
Academic Article
|
A Mistake Not to Be Repeated: What Can We Learn from the Underutilization of Statin Therapy for Efficient Dissemination of Cardioprotective Glucose Lowering Agents?
|
|
Academic Article
|
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
|
|
Academic Article
|
Guideline-Concordant Statin Therapy Use?in Secondary Prevention: Should the Medical Community Wait for Divine Intervention?
|
|
Academic Article
|
National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey.
|
|
Academic Article
|
Burden and predictors of statin use in primary and secondary prevention of atherosclerotic vascular disease in the US: from the National Health and Nutrition Examination Survey 2017-2020.
|
|
Academic Article
|
Statins and Primary Atherosclerotic Cardiovascular Disease Prevention-What We Know, Where We Need to Go, and Why Are We Not There Already?
|
|
Academic Article
|
Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report).
|
|
Academic Article
|
World Heart Federation Cholesterol Roadmap 2022.
|
|
Academic Article
|
Lipid-Lowering Therapy Use and Intensification Among United States Veterans Following Myocardial Infarction or Coronary Revascularization Between 2015 and 2019.
|
|
Academic Article
|
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2022 American Heart Association Scientific Sessions.
|
|
Academic Article
|
What is really new in triglyceride guidelines?
|
|
Academic Article
|
Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease.
|
|
Academic Article
|
The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology.
|
|
Academic Article
|
With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs?
|
|
Academic Article
|
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American College of Cardiology Conference.
|
|
Academic Article
|
Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting.
|
|
Academic Article
|
Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort.
|
|
Academic Article
|
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 European Society of Cardiology Congress.
|